Frosch, Z., Masaquel, A., Reyes, C. M., Cassoli, L., Lai, D., Lo-Rossi, A., Myers, K., Bussberg, C., Patel, K. (2026). Patient preferences regarding bispecific antibody (BsAb) treatment schedules and clinical profiles in second-line or later (2L+) diffuse large B-cell lymphoma (DLBCL).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e23129